Advertisement

Picture BCNP Consultants European Chemistry Partnering 2018 Ffm Germany 600x60px
Document › Details

bioMérieux S.A.. (7/18/16). "Press Release: bioMérieux – Second-Quarter 2016 Business Review". Marcy l’Étoile.

Organisation Organisation bioMérieux S.A. (Euronext: BIM)
  Group Mérieux (Group)
Products Product FilmArray® PCR test (product series)
  Product 2 in vitro diagnostics (IVD)
Person Person Mérieux, Alexandre (bioMérieux 201404– CEO before VP Industrial Microbiology)
     


> Strong growth in sales, up 10.9%, at constant exchange rates and scope of consolidation in the first half of 2016:
Sales reached €1,001 million
Up 7.2% as reported

> Growth continued to be led by the Americas in the second quarter, supported by the return to faster gains in the Asia-Pacific region

> All of the clinical and industrial lines contributed to consolidated growth

> Excellent 62% increase in FilmArray® sales in the second quarter


Alexandre Mérieux, Chief Executive Officer, said: "bioMérieux achieved €1 billion in sales right from the first half, confirming that 2016 has gotten off to a good start. The sustained momentum in the Americas, boosted by the return to faster growth in the Asia-Pacific region, particularly in China, more than offset the modest gains in the EMEA region, helping to drive organic growth in sales of nearly 11% for the six-month period. As was the case in 2015, second-half growth is expected to come in slightly below the first-half performance and set us on a favorable course to fulfilling our ambitions."


bioMérieux, a world leader in the field of in vitro diagnostics, today released its quarterly business review for the six months ended June 30, 2016.


SALES

Consolidated sales rose to €1,001 million in the first six months of 2016 from €933 million in the year-earlier period. This 7.2% reported increase included a negative currency effect of around €26 million as well as the impact of deconsolidating bioTheranostics as from January 1. Year-on-year organic growth (i.e., at constant exchange rates and scope of consolidation) came to 10.9%, led by an acceleration in sales of FilmArray® for around 450 bp and of BioFire Defense solutions for 100 bp.


Download [ of full release at www.biomerieux.com/sites/corporate/files/news-event-press-release/biomerieux_pr_sales_q2_2016_0.pdf ]


   
Record changed: 2016-08-09

Advertisement

Picture EBD Group Cell & Gene Exchange 2017 Washington DC USA May 600x60px

More documents for Mérieux (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture BCNP Consultants European Chemistry Partnering 2018 Ffm Germany 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture BCNP Consultants European Chemistry Partnering 2018 Ffm 120x180px Picture EBD Group Cell & Gene Exchange 2017 Washington DC USA May 120x180px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA September 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Cell & Gene Exchange 2017 Washington DC USA May 120x180px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA September 120x180px Picture BCNP Consultants European Chemistry Partnering 2018 Ffm 120x180px